... III st udies,ACCLAIM /COPD (AClidinium CLinical trial Assessingefficacy and safety In Moderate to severe COPD patients) I and II, to assess the long-term efficacy and safety of * Correspondence: ... of dry mouth, urinary retention and arrhyth-mias [24, 25]. In the ACCL AIM /COPD studies, the inci-dence of anticholinergic AEs was similar between the two groups. Although safety analyses of ... design of the study and the interpretation of the study data. RL supervised the statisticalanalysis. All authors contributed to the development of the manuscript, and read and approved the final...